Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.75 - $2.95 $254,360 - $428,779
145,349 New
145,349 $375,000
Q1 2023

May 15, 2023

SELL
$0.68 - $1.11 $26,910 - $43,927
-39,574 Reduced 30.46%
90,329 $63,000
Q4 2022

Feb 14, 2023

BUY
$0.58 - $1.2 $12,021 - $24,872
20,727 Added 18.98%
129,903 $93,000
Q3 2022

Nov 14, 2022

BUY
$0.66 - $2.32 $23,063 - $81,072
34,945 Added 47.08%
109,176 $72,000
Q2 2022

Aug 16, 2022

SELL
$1.57 - $3.33 $66,442 - $140,925
-42,320 Reduced 36.31%
74,231 $137,000
Q1 2022

May 17, 2022

BUY
$2.76 - $4.64 $84,458 - $141,988
30,601 Added 35.6%
116,551 $375,000
Q4 2021

Feb 15, 2022

BUY
$4.09 - $7.16 $282,901 - $495,250
69,169 Added 412.19%
85,950 $370,000
Q3 2021

Nov 16, 2021

SELL
$5.8 - $8.02 $504,147 - $697,114
-86,922 Reduced 83.82%
16,781 $100,000
Q2 2021

Aug 16, 2021

SELL
$6.87 - $9.16 $344,571 - $459,428
-50,156 Reduced 32.6%
103,703 $859,000
Q1 2021

May 18, 2021

BUY
$7.67 - $13.77 $243,123 - $436,481
31,698 Added 25.95%
153,859 $1.32 Million
Q4 2020

Feb 17, 2021

BUY
$12.07 - $17.95 $856,776 - $1.27 Million
70,984 Added 138.7%
122,161 $1.48 Million
Q3 2020

Nov 17, 2020

SELL
$14.16 - $19.45 $713,763 - $980,416
-50,407 Reduced 49.62%
51,177 $832,000
Q2 2020

Aug 17, 2020

BUY
$6.97 - $17.12 $494,166 - $1.21 Million
70,899 Added 231.05%
101,584 $1.53 Million
Q1 2020

May 15, 2020

SELL
$5.79 - $11.83 $315,485 - $644,593
-54,488 Reduced 63.97%
30,685 $223,000
Q4 2019

Feb 14, 2020

SELL
$3.9 - $6.16 $63,480 - $100,266
-16,277 Reduced 16.04%
85,173 $508,000
Q3 2019

Nov 14, 2019

BUY
$3.01 - $4.49 $107,544 - $160,423
35,729 Added 54.36%
101,450 $429,000
Q2 2019

Aug 15, 2019

BUY
$2.8 - $4.14 $31,337 - $46,334
11,192 Added 20.52%
65,721 $252,000
Q1 2019

May 16, 2019

BUY
$2.35 - $4.19 $65,659 - $117,068
27,940 Added 105.08%
54,529 $226,000
Q4 2018

Feb 15, 2019

SELL
$2.17 - $3.8 $14,647 - $25,650
-6,750 Reduced 20.25%
26,589 $58,000
Q3 2018

Nov 14, 2018

BUY
$3.0 - $4.05 $100,017 - $135,022
33,339 New
33,339 $128,000
Q2 2018

Aug 15, 2018

SELL
$3.15 - $4.7 $327,042 - $487,968
-103,823 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.5 - $4.45 $68,035 - $121,102
27,214 Added 35.52%
103,823 $462,000
Q4 2017

Feb 15, 2018

BUY
$2.35 - $4.0 $180,031 - $306,436
76,609
76,609 $192,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.